SII's executive director for regulatory affairs, Suresh Jadhav, says that moving vaccine R&D to developing countries could eventually cut the cost of new drug development 'by a factor of ten'. Jadhav predicts that companies in Brazil, Cuba and Indonesia will expand their R&D programmes and start creating cheaper drugs and vaccines for use in developing countries.
We encourage you to republish this article online and in print, it’s free under our creative commons attribution license, but please follow some simple guidelines:
- You have to credit our authors.
- You have to credit SciDev.Net — where possible include our logo with a link back to the original article.
- You can simply run the first few lines of the article and then add: “Read the full article on SciDev.Net” containing a link back to the original article.
- If you want to also take images published in this story you will need to confirm with the original source if you're licensed to use them.
- The easiest way to get the article on your site is to embed the code below.
For more information view our media page and republishing guidelines.
The full article is available here as HTML.
Press Ctrl-C to copy